Madrigal Pharmaceuticals (MDGL) Short term Debt (2010 - 2016)
Madrigal Pharmaceuticals (MDGL) posted quarterly Short term Debt of $10000.0 for Q2 2016, down 99.89% year-over-year from $9.2 million in Q3 2015, and down 99.57% quarter-over-quarter from $2.3 million in Q1 2016.
Madrigal Pharmaceuticals (MDGL) Short term Debt (2010 - 2016) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Short term Debt for 7 consecutive years, with $10000.0 the latest figure, recorded in Q2 2016.
- In Q2 2016, Short term Debt fell 99.89% year-over-year to $10000.0; the TTM figure through Jun 2016 stood at $10000.0 (down 99.89% YoY), while the FY2015 annual figure was $4.6 million, down 50.0% from the prior year.
- Short term Debt fell to $10000.0 in Q2 2016 per MDGL's latest filing, from $2.3 million in the prior quarter.
- Across five years, Short term Debt topped out at $9.5 million in Q4 2013 and bottomed at $10000.0 in Q2 2016.
- Historically, Short term Debt has averaged $6.9 million across 5 years, with a median of $7.9 million in 2012.
- Annual changes were most pronounced in 2014 — Short term Debt jumped 200.58% — and 2016, when it sank 99.89%.
- Madrigal Pharmaceuticals' Short term Debt stood at $7.9 million in 2012, then climbed by 19.27% to $9.5 million in 2013, then fell by 2.51% to $9.2 million in 2014, then slumped by 50.0% to $4.6 million in 2015, then slumped by 99.78% to $10000.0 in 2016.
- Business Quant data shows MDGL's Short term Debt at $10000.0 in Q2 2016, $2.3 million in Q1 2016, and $4.6 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 10,000.00 |
| Mar 31, 2016 | 2.30 Mn |
| Dec 31, 2015 | 4.61 Mn |
| Sep 30, 2015 | 6.91 Mn |
| Jun 30, 2015 | 9.21 Mn |
| Mar 31, 2015 | 9.22 Mn |
| Dec 31, 2014 | 9.21 Mn |
| Sep 30, 2014 | 9.21 Mn |
| Jun 30, 2014 | 9.20 Mn |
| Mar 31, 2014 | 9.26 Mn |
| Dec 31, 2013 | 9.45 Mn |
| Sep 30, 2013 | 7.39 Mn |
| Jun 30, 2013 | 5.31 Mn |
| Mar 31, 2013 | 3.08 Mn |
| Dec 31, 2012 | 7.92 Mn |
| Sep 30, 2012 | 7.90 Mn |
| Jun 30, 2012 | 7.88 Mn |
| Mar 31, 2012 | 6.06 Mn |
| Dec 31, 2011 | 4.23 Mn |
| Sep 30, 2011 | 4.61 Mn |